Winway Health Desk
On the heels of CFO scandal, former Eli Lilly exec alleges...
Eli Lilly faced a high-level personnel scandal last month when CFO Josh Smiley left under a cloud of "inappropriate" communications with employees. But a...
Johnson & Johnson vaccine partner Emergent still lacks FDA’s manufacturing green...
The U.S. manufacturing partner turning out drug substance for Johnson & Johnson's single-dose COVID-19 vaccine is still waiting on an FDA green light, potentially...
General Catalyst leads $101M investment in startup helping pharma build digital...
BrightInsight’s co-founders, from left to right: Vice President of Engineering and Data Science Ben Lee, CTO Ferry Tamtoro, CEO Dr. Kal Patel. Photo credit:...
Eohilia maker Takeda targets doctors in a first-time eosinophilic esophagitis awareness...
Until a few years ago, eosinophilic disorders were largely invisible. Only medical specialists and diagnosed patients knew they existed.
Thanks in part to marketing campaigns...
As clinical trials move off-site, legal teams prepare for new challenges
The Covid-19 pandemic forever changed how the life sciences industry operates. Seemingly overnight, doctors, nurses, and researchers had to transition their practices from in-person...
FDA snubs Keytruda in early breast cancer after harsh review as...
The other shoe has dropped for Merck’s U.S. application of Keytruda in high-risk early-stage triple-negative breast cancer.
As expected, the FDA has rejected the blockbuster...
Omega Therapeutics adds $126M to move “programmable” drugs closer to the...
When Omega Therapeutics pulled back the curtains for a peek at its work last summer, it revealed a new class of medicines that regulate...
Pfizer, BioNTech amp up COVID-19 vaccine dose target again—this time to...
Pfizer and BioNTech have hustled to produce as many COVID-19 vaccine doses as possible this year, and that effort keeps paying off. After jacking up their...
Cleveland Clinic, IBM launch 10-year tech-enabled research partnership
Cleveland Clinic has struck a new partnership with technology giant IBM to turbocharge its research activities over the next decade.
The 10-year collaboration will create...
FDA Approves New Indication & New Product Formulation for Myrbetriq for...
TOKYO, March 26, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food...
